Results 31 to 40 of about 12,289 (268)

Comparison of Placenta Previa and Placenta Accreta Spectrum Disorder Following Previous Cesarean Section between Women with a Short and Normal Interpregnancy Interval

Obstetrics and Gynecology International, 2022
Objectives. The aim of this study is to determine the effect of interpregnancy interval (IPI) on the incidence of placenta previa and placenta accreta spectrum disorders in women with a previous cesarean section. Methods.
Uchenna Anthony Umeh, George Uchenna Eleje, Justus Uchenna Onuh, Ogochukwu Theophilus Nwankwo, Ijeoma Victoria Ezeome, Leonard Ogbonna Ajah, Ngozi Regina Dim, Samuel Nnamdi Obi, Chidebe Christian Anikwe, Joseph Ifeanyichukwu Ikechebelu   +9 more
doaj   +1 more source

Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study

Scientific Reports
This study aimed to identify the risk factors for placenta accreta spectrum (PAS) in women who had at least one previous cesarean delivery and a placenta previa or low-lying.
G. Kayem, A. Seco, Françoise Vendittelli, Catherine Crenn Hebert, Corinne Dupont, B. Branger, Cyril Huissoud, J. Fresson, N. Winer, Bruno Langer, P. Rozenberg, O. Morel, M. Bonnet, F. Perrotin, E. Azria, L. Carbillon, C. Chiesa, P. Raynal, René-Charles Rudigoz, S. Patrier, G. Beucher, Michel Dreyfus, Loïc Sentilhes, C. Deneux‐Tharaux   +23 more
semanticscholar   +1 more source

Serum exosomal microRNA pathway activation in placenta accreta spectrum: pathophysiology and detectionAJOG Global Reports at a Glance

AJOG Global Reports
BACKGROUND: Placenta accreta spectrum disorders are a complex range of placental pathologies that are associated with significant maternal morbidity and mortality.
Jessian L. Munoz, MD, PhD, MPH, Brett D. Einerson, MD, Robert M. Silver, MD, Sureshkumar Mulampurath, PhD, Lauren S. Sherman, PhD, Pranela Rameshwar, PhD, Egle Bytautiene Prewit, PhD, Patrick S. Ramsey, MD, MSPH   +7 more
doaj   +1 more source

Conservative Management of Placenta Accreta Spectrum [PDF]

Clinical Obstetrics & Gynecology, 2018
The purpose of this review was to assist obstetricians and gynecologists in considering the most appropriate conservative treatment option to manage women with placenta accreta spectrum according to their individual need and local expertise of the heath care team. The issue is challenging, as the quality of evidence with regard to efficacy is poor, and
Sentilhes, Loïc, Kayem, Gilles, Silver, Robert   +2 more
openaire   +2 more sources

Damage-Control Surgery for Maternal Near-Miss Cases of Placenta Previa and Placenta Accreta Spectrum

International Journal of Women's Health, 2021
Abdulrahim A Rouzi, Mohammed Sulaimani Department of Obstetrics and Gynecology, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence: Abdulrahim A RouziDepartment of Obstetrics and Gynecology, King Abdulaziz University, PO Box 80215, Jeddah ...
Rouzi AA, Sulaimani M
doaj  

Looking back to look forward: Has the time arrived for active management of obstetricians in placenta accreta spectrum?

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Placenta accreta spectrum (PAS) is a relatively new obstetric condition which, until recently, was poorly understood. The true incidence is unknown because of the poor quality and heterogeneous diagnostic criteria.
H. Bartels, Paul Downey, Donal J. Brennan   +2 more
semanticscholar   +1 more source

Obstetric characteristics and maternal outcomes of early second‐trimester placenta accreta spectrum

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To describe early second‐trimester placenta accreta spectrum (PAS) management and outcomes. Methods This cross‐sectional study queried the US Healthcare Cost and Utilization Project's National Inpatient Sample from 2016 to 2021, finding 905 cases with a diagnosis of PAS between 14 and 22 weeks of gestation and in‐hospital management.
Mihiri S. Karunaratne, Shinya Matsuzaki, Kazuhide Matsushima, Jane L. Yang, Rachel S. Mandelbaum, Laila I. Muderspach, Joseph G. Ouzounian, Koji Matsuo, Brian T. Nguyen   +8 more
wiley   +1 more source

A risk factor profile for placenta accreta spectrum in pregnancies conceived with assisted reproductive technology

F&S Reports, 2023
Objective: To identify independent risk factors for placenta accreta spectrum among pregnancies conceived with assisted reproductive technology. Design: Retrospective cohort study. Setting: Tertiary hospital.
Daniela A. Carusi, M.D., Daksha Gopal, M.P.H., Howard J. Cabral, Ph.D., Catherine Racowsky, Ph.D., Judy E. Stern, Ph.D.   +4 more
doaj   +1 more source

Prophylactic Radiologic Interventions for Postpartum Hemorrhage Control in Women With Placenta Accreta Spectrum Disorder

Obstetrics and Gynecology
Prophylactic placement of balloon catheters or sheaths before planned cesarean delivery in women with placenta accreta spectrum disorder may reduce perioperative blood loss.
Lisanne R Bonsen, Kosma Sleijpen, Joris R H Hendriks, T. Urlings, O. M. Dekkers, S. le Cessie, Marc van de Velde, Pema Gurung, T. van den Akker, J. G. van der Bom, D. Henriquez   +10 more
semanticscholar   +1 more source

Neonatal outcomes in the surgical management of placenta accreta spectrum disorders: a retrospective single-center observational study from 468 Vietnamese pregnancies beyond 28 weeks of gestation

BMC Pregnancy and Childbirth
- The increased rate of poor neonatal outcomes in PASDs is mainly related to emergency cesarean section. - The MOSCUS method and Cesarean hysterectomy are likely similar to the risk of adverse neonatal outcomes.
PHUC NHON NGUYEN, A. Vuong, X. T. Pham
semanticscholar   +1 more source